GlassScriptPhysician profile
Xiongfei Liu
NPI 1497135156
$81,517.56
in general payments reported to CMS, 2019-2025
26 companies · $20K in 2025
The $20K reported for 2025 was more than what 97% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $615 · 2020: $349 · 2021: $15K · 2022: $4,235 · 2023: $24K · 2024: $18K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $29K · Consulting Fee: $18K · Food and Beverage: $9,853 · Travel and Lodging: $4,296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $29,015.00 |
| Consulting Fee | $18,090.00 |
| Food and Beverage | $9,853.35 |
| Travel and Lodging | $4,295.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $37,175.15 | 2019-2025 | Hydrus Microstent, Voyager Dslt, Clareon |
| Glaukos Corporation | $13,182.23 | 2019-2025 | Travoprost Intraocular Implant - Idose, Idose, Istent Trabecular Micro-Bypass Stent System |
| Aerie Pharmaceuticals, INC. | $9,906.81 | 2020-2021 | |
| Alcon Research LLC | $6,370.00 | 2023 | Hydrus Microstent |
| Abbvie INC. | $4,397.62 | 2022-2025 | |
| Sight Sciences, INC. | $4,055.67 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Bausch & Lomb Americas INC. | $1,542.25 | 2022-2025 | Vyzulta, Envista Mx60 Iol, Ic-8 Apthera Iol |
| Allergan, INC. | $1,125.08 | 2021-2022 | |
| New World Medical,INC. | $1,023.43 | 2021-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Ivantis, INC | $976.43 | 2019-2021 | |
| Rxsight INC | $317.65 | 2022-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Nova Eye, INC. | $217.43 | 2022-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $213.40 | 2021 | |
| Oyster Point Pharma, INC. | $133.54 | 2022-2023 | Tyrvaya |
| Horizon Therapeutics Plc | $124.99 | 2023 | Tepezza |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $124.26 | 2019 | |
| Apellis Pharmaceuticals, INC. | $119.93 | 2023 | |
| Kala Pharmaceuticals, INC. | $119.06 | 2021 | |
| Iridex Corporation | $95.78 | 2021-2022 | |
| Thea Pharma INC. | $90.34 | 2023-2025 | Iyuzeh |
| Sun Pharmaceutical Industries INC. | $75.74 | 2024-2025 | |
| Amgen INC. | $50.50 | 2024-2025 | Tepezza |
| Harrow Eye, LLC | $25.66 | 2024 | Vevye |
| Carl Zeiss Meditec USA, INC. | $21.83 | 2021 | |
| Dompe US, INC. | $18.34 | 2025 | Oxervate |
| Mallinckrodt Hospital Products INC. | $14.44 | 2024 | Acthar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiongfei Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.